POLSKI INSTYTUT FARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5213818170

KRS0000723567

Share capital100,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. DOMANIEWSKA 37 / 2.43, 02-672 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

POLSKI INSTYTUT FARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. DOMANIEWSKA 37 / 2.43, 02-672 WARSZAWA

Show on map

NIP

5213818170

REGON

369739340

KRS

0000723567

Legal form

limited liability company

Register Address

UL. DOMANIEWSKA 37 / 2.43, 02-672 WARSZAWA

Date of registration in KRS

2018-03-19

Date of commencement of economic activity

2018-03-19

Act signature

RDF/703484/25/121

Pkd codes

46.90.Z - Non-specialized wholesale trade

10.86.Z - Production of homogenized food products and diet food

10.89.Z - Production of other food products, not elsewhere classified

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

32.99.Z - Production of other products not classified elsewhere

72.11.Z - Scientific research and development activities

72.19.Z - Scientific research and development activities

Payer VAT status

Active

Vat list bank account(s)

PL03 1020 3541 0000 5202 0341 6757

Company authorities

representation authorityMANAGEMENT

representation type

DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST UPOWAŻNIONY KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE.

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,4	0,9	0,9	-3,9
EBITDA	0,4	0,9	0,9	-1,6
Short time liabilities	0,2	0,2	0,2	32,4
Equity capital	0,5	1,3	2,2	63,5
Operating profit (EBIT)	0,4	0,9	0,9	-3,9
Assets	1,6	1,9	2,8	47,1
Net profit (loss)	0,4	0,9	0,9	-3,9
Cash	0,3	0,1	0,9	949,8
Net income from sale	3,3	6	6,9	14,9
Liabilities and provisions for liabilities	1,2	0,6	0,6	9,6
Working assets	1,5	1,9	2,8	49,4
Depreciation	0	0,1	0,1	34,9
	%	%	%	p.p.
Profitability of capital	80,1	66,1	38,8	-27,3
Equity capital to total assets	28,3	69,6	77,4	7,8
Gross profit margin	11,9	14,9	12,4	-2,5
EBITDA Margin	11,4	15,8	13,5	-2,3
	Days	Days	Days	Days
Short term commitment turnover cycle	17	11	13	2

Current financial liquidity indicator	9.492997169494629	10.197168350219727	11.503422737121582	1,3
Net dept to EBITDA	1.936601996421814	0.33371949195861816	-0.5830521583557129	-0,9